4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-097370
Chief Development Officer sold 4,879 shares at an average $73.48 ($358,495)
- Chief Development Officer acquired 4,879 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-07-17 | Option exercise 10b5-1 | +4,379 | $21.65 | $94,805 | 9,866 | D: show line 1 in the form |
| Guyer William Chief Development Officer | 2025-07-17 | Sale 10b5-1 | −4,379 | $73.48 | $321,774 | 5,487 | D: show line 2 in the form |
| Guyer William Chief Development Officer | 2025-07-18 | Option exercise 10b5-1 | +500 | $21.65 | $10,825 | 5,987 | D: show line 3 in the form |
| Guyer William Chief Development Officer | 2025-07-18 | Sale 10b5-1 | −500 | $73.44 | $36,721 | 5,487 | D: show line 4 in the form |
| Open-market sales · 4,879 sh · avg $73.48 · $358,495 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-07-17 | Option exercise · Stock option (right to buy) 10b5-1 | −4,379 | 385,521 | D: show line 5 in the form | ||
| Guyer William Chief Development Officer | 2025-07-18 | Option exercise · Stock option (right to buy) 10b5-1 | −500 | 385,021 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…